These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


587 related items for PubMed ID: 9763856

  • 61. Paraneoplastic nervous system syndromes.
    Jaeckle KA.
    Curr Opin Oncol; 1996 May; 8(3):204-8. PubMed ID: 8794147
    [Abstract] [Full Text] [Related]

  • 62. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
    de Beukelaar JW, Verjans GM, van Norden Y, Milikan JC, Kraan J, Hooijkaas H, Sintnicolaas K, Gratama JW, Sillevis Smitt PA.
    Cancer Immunol Immunother; 2007 Sep; 56(9):1501-6. PubMed ID: 17597332
    [Abstract] [Full Text] [Related]

  • 63. Paraneoplastic syndromes associated with anti-Hu antibodies.
    Senties-Madrid H, Vega-Boada F.
    Isr Med Assoc J; 2001 Feb; 3(2):94-103. PubMed ID: 11344832
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Paraneoplastic pemphigus: a brief update.
    Wade MS, Black MM.
    Australas J Dermatol; 2005 Feb; 46(1):1-8; quiz 9-10. PubMed ID: 15670168
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.
    Nguyen VT, Ndoye A, Bassler KD, Shultz LD, Shields MC, Ruben BS, Webber RJ, Pittelkow MR, Lynch PJ, Grando SA.
    Arch Dermatol; 2001 Feb; 137(2):193-206. PubMed ID: 11176692
    [Abstract] [Full Text] [Related]

  • 70. [Recent advances in paraneoplastic encephalomyeloneuronopathy].
    Sakai K.
    Nihon Rinsho; 1994 Nov; 52(11):3006-12. PubMed ID: 7996702
    [Abstract] [Full Text] [Related]

  • 71. Anti-tumour therapy in paraneoplastic neurological disease.
    Grisold W, Drlicek M, Liszka-Setinek U, Wondrusch E.
    Clin Neurol Neurosurg; 1995 Feb; 97(1):106-11. PubMed ID: 7788965
    [Abstract] [Full Text] [Related]

  • 72. Clinical analysis of anti-Ma2-associated encephalitis.
    Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B, Saiz A, Meneses P, Rosenfeld MR.
    Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
    [Abstract] [Full Text] [Related]

  • 73. [Mechanisms of paraneoplastic neurologic syndromes].
    Honnorat J, Rogemond V, Antoine JC.
    Rev Med Interne; 1999 Aug; 20(8):670-80. PubMed ID: 10480170
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Neuroimmunology of the paraneoplastic neurological degenerations.
    Roberts WK, Darnell RB.
    Curr Opin Immunol; 2004 Oct; 16(5):616-22. PubMed ID: 15342008
    [Abstract] [Full Text] [Related]

  • 76. Paraneoplastic neurological syndromes.
    Honnorat J, Antoine JC.
    Orphanet J Rare Dis; 2007 May 04; 2():22. PubMed ID: 17480225
    [Abstract] [Full Text] [Related]

  • 77. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis.
    Rosenfeld MR, Dalmau JO.
    Continuum (Minneap Minn); 2012 Apr 04; 18(2):366-83. PubMed ID: 22810133
    [Abstract] [Full Text] [Related]

  • 78. Paraneoplastic neurological syndromes: a review.
    Toothaker TB, Rubin M.
    Neurologist; 2009 Jan 04; 15(1):21-33. PubMed ID: 19131854
    [Abstract] [Full Text] [Related]

  • 79. [Diagnosis of paraneoplastic neurological syndromes].
    Kovács GG, Voigtländer T.
    Orv Hetil; 2004 Oct 03; 145(40):2027-33. PubMed ID: 15559529
    [Abstract] [Full Text] [Related]

  • 80. [Paraneoplastic neurological syndrome--definition and history].
    Inuzuka T.
    Brain Nerve; 2010 Apr 03; 62(4):301-8. PubMed ID: 20420169
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 30.